Aprogen Pharmaceuticals
Aprogen Pharmaceuticals is a South Korea-based, privately-held pharmaceutical manufacturer established in 1960 that produces and sells anti-cancer drugs and digestive aid medicines, employing 251-500 staff at its Seongnam operations.
- Company typePrivate
- Founded1960
- HeadquartersSeongnam, South Korea
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Aprogen Pharmaceuticals firmographics
Firmographics- Name
- Aprogen Pharmaceuticals
- Website
- https://aprogen-pharm.com
- Company type
- Private
- Founded year
- 1960
- Headcount range
- 251–500 employees
- Short description
- Aprogen Pharmaceuticals is a South Korea-based, privately-held pharmaceutical manufacturer established in 1960 that produces and sells anti-cancer drugs and digestive aid medicines, employing 251-500 staff at its Seongnam operations.
- Ownership category
- akta.pro rank
Aprogen Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where Aprogen Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Seongnam
- HQ country
- South Korea
- HQ region
- Asia
Markets served
Aprogen Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Aprogen Pharmaceuticals product offering
Product offeringCore offering
Aprogen Pharmaceuticals manufactures and sells pharmaceutical products, with a portfolio that includes anti-cancer drugs and digestive aid medicines. The company develops and produces drug formulations serving therapeutic areas in oncology and gastroenterology, with manufacturing operations based in Seongnam, South Korea, and a biologics drug development arm.
Differentiator
Problem solved
Functional benefit
Products and services
- Anti-cancer drugs Manufactured pharmaceutical products used in oncology treatment, sold to healthcare providers, hospitals, and pharmaceutical distributors.
- Digestive aid medicine Manufactured gastrointestinal pharmaceutical formulations sold to healthcare providers, hospitals, and pharmaceutical distributors.
Companies that use Aprogen Pharmaceuticals
Customer profileIdeal customer profiles1 record
Aprogen Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Aprogen Pharmaceuticals competitors and assessment
Company assessmentEmerging players
- Celltrion: Korean biopharmaceutical leader focused on biosimilars and biologics. Comparable given Aprogen's separate biologics platform (aprogen-biologics.com) and overlapping specialty/biologics development ambitions in Korea.
- LG Chem Life Sciences: Korean life-sciences business investing in specialty and biologics pipelines. Comparable as a domestic Korea-based player expanding into specialty therapeutics and biologics, the same categories where Aprogen is increasing exposure.
Broad incumbents
- Samsung Biologics: World-scale Korean biologics contract manufacturer. Comparable as a domestic biologics manufacturing capability alternative, particularly relevant as Aprogen expands its biologics platform.
- Yuhan Corporation: One of the largest Korean pharmaceutical companies, spanning prescription drugs, OTC, and consumer health (digestive care). Comparable given Aprogen's digestive-aid and specialty pharma positioning within the same Korean industry.
- GC Biopharma (formerly Green Cross): Korean biopharma with vaccines, plasma products, and specialty therapeutics. Comparable as a domestic competitor with biologics manufacturing breadth intersecting Aprogen's pharmaceutical and biologics activities.
- Daewoong Pharmaceutical: Established Korean pharmaceutical manufacturer with a domestic + international generics and specialty footprint. Comparable as a Korea-headquartered pharma manufacturer competing in similar therapeutic and commercial channels.
- Hanmi Pharmaceutical: Major South Korean specialty pharma firm with oncology and specialty-care drug development. Comparable as a domestic Korean pharma competitor operating in specialty and primary care categories where Aprogen also competes.
Direct peers
- Dong-A Pharmaceutical: Mid-to-large Korean pharmaceutical manufacturer with a mix of prescription, OTC, and consumer health products including GI-related offerings. Comparable as a Korea-based pharma competitor overlapping in primary-care/digestive categories.
- Boryung Pharmaceutical: Korean pharmaceutical company with a primary-care and specialty product mix including GI and related therapeutic categories. Comparable as a mid-sized Korean peer competing for similar domestic distribution and prescription share.
- Nichi-Iko Pharmaceutical: Japan's largest generic pharmaceutical manufacturer and a strategic investor in Aprogen via multiple funding rounds. Highly comparable in generics-and-specialty-pharma manufacturing, and the lead-buyer relationship signals overlapping customer channels and product mix.
Market position
Customer concentration
Aprogen Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aprogen Pharmaceuticals leadership team
Management profileNumber of profiles
Aprogen Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aprogen Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aprogen Pharmaceuticals
What does Aprogen Pharmaceuticals do?
Aprogen Pharmaceuticals manufactures and sells pharmaceutical products, with a portfolio that includes anti-cancer drugs and digestive aid medicines. The company develops and produces drug formulations serving therapeutic areas in oncology and gastroenterology, with manufacturing operations based in Seongnam, South Korea, and a biologics drug development arm.
When was Aprogen Pharmaceuticals founded?
Aprogen Pharmaceuticals was founded in 1960. It employs 251 to 500 people.
Where is Aprogen Pharmaceuticals based?
Aprogen Pharmaceuticals is headquartered in Seongnam, South Korea, in the Asia region.
Who are Aprogen Pharmaceuticals's main competitors?
Emerging players on record are Celltrion and LG Chem Life Sciences. Broad incumbents are Samsung Biologics, Yuhan Corporation, GC Biopharma (formerly Green Cross), Daewoong Pharmaceutical and Hanmi Pharmaceutical. Direct peers are Dong-A Pharmaceutical, Boryung Pharmaceutical and Nichi-Iko Pharmaceutical.
Does Aprogen Pharmaceuticals have an API?
No public API is recorded for Aprogen Pharmaceuticals.
What industry is Aprogen Pharmaceuticals in?
Aprogen Pharmaceuticals's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAI, Gastroenterology & Hepatology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.